Safety and efficacy of subcutaneous tocilizumab for patients with systemic-onset juvenile idiopathic arthritis
Not Applicable
- Conditions
- Systemic-onset juvenile idiopathic arthritis(sJIA)
- Registration Number
- JPRN-UMIN000023036
- Lead Sponsor
- Department of Pediatrics, Yokohama City University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
1. Pulmonary tuberculosis, active bacterial infection or deep mycotic infection 2. Infection of HIV, HCV or HBV 3. Pregnant subjects or subjects who do not agree with contraception during the study period
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Maintenance of remission
- Secondary Outcome Measures
Name Time Method Improvement of QO